Sep 2, 2026 08:00AM
Aug 31, 2026 08:32AM
Aug 31, 2026 08:30AM
Aug 12, 2026 04:05PM
Aug 5, 2026 08:30AM
Aug 5, 2026 08:30AM
Jul 21, 2026 04:30PM Acrivon to Highlight the Power of its AP3 Platform for Streamlined, Pathway-Based Drug Discovery and Development with Oral and Poster Presentations at AACR D3 Conference
May 21, 2026 07:30AM
May 15, 2026 04:00PM
May 13, 2026 04:10PM
May 13, 2026 04:10PM
Apr 17, 2026 04:00PM
Apr 17, 2026 04:00PM
Apr 15, 2026 04:05PM Acrivon Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Mar 19, 2026 07:21AM
Mar 17, 2026 05:54PM
Mar 2, 2026 03:39PM
Feb 24, 2026 08:00AM
Feb 23, 2026 08:00AM
Feb 18, 2026 08:00AM
Feb 17, 2026 10:48AM Registration Momentum Builds Across the Oncology Pipeline
Jan 23, 2026 08:13AM
Jan 23, 2026 08:11AM
Jan 8, 2026 07:32AM
Jan 8, 2026 07:30AM
Jan 6, 2026 07:30AM
Jan 6, 2026 07:30AM
Dec 17, 2025 09:34AM Acrivon Therapeutics to host webcast on clinical trial updates in January
Dec 17, 2025 09:34AM
Dec 17, 2025 07:30AM
Dec 17, 2025 07:30AM
Nov 13, 2025 04:10PM
Oct 22, 2025 04:27PM
Oct 22, 2025 04:15PM
Oct 1, 2025 04:30PM Acrivon Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Aug 13, 2025 04:15PM
May 15, 2025 07:26AM
May 14, 2025 04:10PM
Apr 25, 2025 08:00AM
Apr 7, 2025 04:05PM
Apr 7, 2025 04:05PM
Mar 27, 2025 05:44PM Acrivon Therapeutics Provides Program Updates and Fourth Quarter and Full Year 2024 Financial Results
Mar 19, 2025 08:00AM
Mar 19, 2025 08:00AM
Feb 5, 2025 08:00AM
Feb 5, 2025 08:00AM
Nov 13, 2024 07:00AM
Oct 17, 2024 08:00AM
Oct 16, 2024 04:00PM Acrivon Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Oct 11, 2024 08:03AM

330,650 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All